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Immune reactive cytokines, such as interferon (IFN)-c, have
multiple effects in glomerulonephritis. Superoxide anions
(O2
), which are associated with the progression of
glomerulonephritis, are mainly generated by nicotinamide
adenine dinucleotide phosphate (reduced form) NAD(P)H
oxidases. We determined the effects of IFN-c on O2

production, phosphorylation of signal transducer and
activator of transcription (STAT)-1a, and the mRNA and
protein expressions of p22phox and Nox1, components of
NAD(P)H oxidases, in human mesangial cells (HMCs).
Significant increases in O2
 production with IFN-c were
completely abolished by the flavin-containing enzyme
inhibitor, diphenyleneiodonium (10 lmol/l), and the
Janus-activated kinase (JAK)2 inhibitor, AG490 (100 lmol/l).
Phosphorylated STAT-1a was detected after 5 min of IFN-c
stimulation using Western blot analysis, and binding to the
gamma-activating site was observed from 30 min to 4 h,
thereafter by electrophoretic mobility shift assay (EMSA).
Super-shift analysis in EMSA revealed that the main
transcription factor was STAT-1a. IFN-c significantly increased
the expression of p22phox mRNA and protein, although
expression was inhibited by AG490. These data suggest that
IFN-c stimulates O2
 production in HMCs via the JAK–STAT
pathway and NAD(P)H oxidase.
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Interferon (IFN)-g, a proinflammatory factor produced by T
helper 1 cells, mediates biological actions such as macrophage
activation, antiviral activity, and production of free radicals.1
Previous reports have indicated that IFN-g is associated with
kidney inflammation including nephritis and arteriosclero-
sis.2,3 Serum levels and intrarenal expression of IFN-g
increases in human nephritis,4,5 and IFN-g gene polymorph-
isms influence disease susceptibility and progression in
human chronic glomerulonephritis.6 In in vitro experiments,
the signal-transduction pathway of IFN-g has been elucidated
in immune-responsive cells. IFN-g usually binds to a specific
membrane receptor and activates receptor-associated Janus-
activated kinase (JAK)1 and JAK2.1 JAK1 and JAK2 activate
the signal transducer and activator of transcription-1a
(STAT-1a) with phosphorylation of the tyrosine residue,
which forms homodimers that translocate to the nucleus.
This induces transcription via binding to the gamma-
activating site (GAS) in IFN-g-inducible promoters and
provokes the production of various proteins.1 These
molecular mechanisms of IFN-g signal-transduction systems
have been found in immune-responsive cells; recently, the
mechanism has also been reported in glomerular mesangial
cells. Choudhury7 reported that IFN-g stimulates protein
kinase C-e in a phosphatidylinositol 3-kinase-sensitive
manner to activate the mitogen-activated protein kinase that
regulates STAT-1a transcriptional activity. However, the
molecular mechanisms by which IFN-g progresses renal
injury have not been elucidated.
We previously reported that reactive oxygen species (ROS)
have important roles in the pathogenesis of diseases such as
arteriosclerosis and hypertension.8,9 Enhanced ROS produc-
tion has also been reported in human and experimental
glomerulonephritis.10 Infiltrated polymorphonuclear leuko-
cytes and monocytes are recognized as an important source
of ROS in the kidney, and resident glomerular cells, such as
mesangial cells, also release oxidants in response to injury.11
Further, one of the major sources of superoxide (O2
) in the
kidney is nicotinamide adenine dinucleotide phosphate
(reduced form) (NAD(P)H) oxidase in mesangial cells.12
Recent studies have shown that three isoforms of the
components of NAD(P)H oxidase, Nox1, gp91phox, and
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Nox4 are found in the kidney.13 Jones et al.12 reported that
the other NAD(P)H oxidase components, p22phox, p47phox,
and p67phox, are expressed in cultured human mesangial
cells (HMCs). Circulating vasoactive peptides and inflam-
matory cytokines including IFN-g also stimulate ROS
production in nephropathy.2,14 However, the molecular and
cell signaling mechanisms of ROS production by IFN-g have
not been clarified.
We hypothesized that IFN-g, which is induced under
inflammatory conditions, regulates NAD(P)H oxidase com-
ponents and that IFN-g is a candidate for ROS-associated
glomerular damage in human nephritis. To ascertain the
molecular mechanisms and the signaling pathway of IFN-g in
cultured HMCs, we investigated the effects of IFN-g on the
JAK–STAT pathway, the expression of NAD(P)H oxidase
components and ROS production.
RESULTS
Effects of IFN-c on STAT phosphorylation
To clarify the mechanism underlying IFN-g-induced tran-
scription in HMCs, we performed Western blot analysis and
electrophoretic mobility shift assay (EMSA). As shown in
Figure 1a, 5-min exposure to IFN-g increased the phosphor-
ylation of STAT-1a by 1.8-fold relative to the unstimulated
control. Hence, IFN-g did not alter the expression of STAT-1a
protein at any time (Figure 1a, lower picture), and indicates
that IFN-g phosphorylated STAT-1a in cultured HMCs. The
STAT-1a phosphorylation after 5-min incubation with IFN-g
was partially inhibited by AG490 (100 mmol/l), a JAK2
inhibitor (Figure 1b). Diphenyleneiodonium (DPI) did
not affect the STAT-1a phosphorylation (Figure 1c). These
data indicate that IFN-g phosphorylates STAT-1a via the
JAK–STAT pathway.
We then performed EMSA using the GAS element as the
radiolabeled oligonucleotide probe. Figure 2a shows that
IFN-g promoted binding of nuclear extracts to the GAS
sequence of HMCs. There was binding activity to the GAS
element after 5-min treatment with IFN-g. Binding activity
peaked at 30 min and was retained for 4 h. The specificity of
IFN-g-promoted binding was confirmed by competitively
inhibiting this reaction with a 50-fold excess of non-labeled
GAS oligonucleotide. We also measured the effect of the
antibody to STAT-1a on the migration of the DNA–protein
complex by EMSA. In Figure 2b, the broken arrow in lane 3
indicates the ‘super-shifted’ band induced by the STAT-1a
antibody (8 mg/ml). The DNA–protein complex associated
with the GAS element was super-shifted by pre-incubation
with the STAT-1a antibody, indicating that the complex
consists of STAT-1a. These data show that IFN-g activates
STAT-1a, and that activated STAT-1a binds to the GAS
sequence in cultured HMCs.
Effects of IFN-c on the expression of p22phox and Nox1
Using Northern blot analysis, we investigated the time course
of p22phox mRNA expression in cultured HMCs treated with
IFN-g; we detected p22phox mRNA (Figure 3a) and found
that IFN-g significantly upregulated its expression from 3 to
24 h relative to glyceraldehyde-3-phosphate dehydrogenase
(Figure 3, lower panel). We also detected Nox1 mRNA;
however, IFN-g did not increase the expression of Nox1
mRNA (Figure 3b). We measured the protein expression of
p22phox using Western blot analysis. IFN-g significantly
increased p22phox protein at 6, 12, and 24 h relative to
b-actin (Figure 4a). The JAK2 inhibitor AG490 (100 mmol/l)
completely inhibited the increase of p22phox induced by
IFN-g (Figure 4b), whereas DPI did not affect p22phox
protein expression (Figure 4c). These data indicate that IFN-g
increases p22phox mRNA and protein expression via the
JAK–STAT pathway.
Effects of IFN-c on O2
 production
Using lucigenin-enhanced chemiluminescence, we analyzed
the time course of O2
 production in HMCs treated with
IFN-g (1000 IU/ml). As shown in Figure 5a, IFN-g gradually
increased the amount of O2
, with significant two- and 2.8-
fold increases at 12 and 24 h, respectively. To confirm the
involvement of NAD(P)H oxidase, we examined the effect of
DPI, a flavin-containing enzyme inhibitor. The IFN-g-
mediated increase in the amount of O2
 at 24 h was
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Figure 1 | Effect of IFN-c on the phosphorylation of STAT-1a in
HMCs. (a) Western blot analysis using phosphorylated STAT-1a
(p-STAT-1a) and STAT-1a antibody (upper and lower pictures,
respectively) shows that IFN-g increased phosphorylation of STAT-1a
within 5 min, but did not change STAT-1a protein levels. Values
represent the mean7s.e. of four independent experiments. *Po0.01
vs control. (b) Western blot analysis using p-STAT-1a and STAT-1a
antibody (upper and lower pictures, respectively) shows that the
JAK2 inhibitor AG490 inhibited the IFN-g-induced phosphorylation
of STAT-1a at 5 min. Values represent the mean 7 s.e. of four
independent experiments. *Po0.01 vs control. (c) Western blot
analysis using p-STAT-1a and STAT-1a antibody (upper and lower
pictures, respectively) shows that flavin-containing enzyme inhibitor
DPI inhibited the IFN-g-induced phosphorylation of STAT-1a at 5 min.
Values represent the mean7s.e. of four independent experiments.
*Po0.05 vs unstimulated control. **Po0.05 vs unstimulated control
with DPI.
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completely inhibited by 10 mmol/l DPI (Figure 5b). The O2

production induced by IFN-g was attenuated by 100 mmol/l
AG490 (Figure 5b). Transfection with p22phox-specific small
interfering RNA (siRNA), but not of scrambled siRNA,
attenuated the IFN-g-mediated increase (Figure 5c). These
data are consistent with the hypothesis that O2
 is induced by
IFN-g partially via the JAK–STAT pathway and by NAD(P)H
oxidase.
DISCUSSION
IFN-g is a proinflammatory cytokine that primarily increases
the local inflammatory response and has multiple effects in
glomerulonephritis.2 IFN-g reduces cell proliferation and
collagen production in glomerular cells,15,16 increases glo-
merular macrophage infiltration and activation, and med-
iates renal injury.17 In the crescentic glomerulonephritis
STAT-1
antibody
+IFN- +
+−−
−
2412813010 20 420 5 Comp.Free
IFN- (1000 U/ml ) IFN- (1000 U/ml )
600 30 0
Min Min h
Free probe
a b
Figure 2 | Binding of the nuclear protein from IFN-c-stimulated HMCs to the GAS element. (a) EMSA was performed using nuclear extracts
isolated from HMCs stimulated by IFN-g for the indicated times, and oligonucleotide probes corresponding to the GAS element. Left picture
shows short-time and right picture shows long-time electrophoresis. Four identical experiments were performed to confirm reproducibility.
Comp., competition experiment; Free., probe only. (b) EMSA was performed using an anti-STAT-1a antibody. The arrow indicates the
protein–DNA complex stimulated by IFN-g. The arrow with a broken line indicates the super-shifted band of the DNA–protein complex
in the presence of the STAT-1a antibody. Three identical experiments were performed to confirm reproducibility.
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Figure 3 | Effect of IFN-c on p22phox mRNA expression.
(a) Northern blot analysis using a radiolabeled oligonucleotide
probe of p22phox. The chart illustrates the density ratio of p22phox
to glyceraldehyde-3-phosphate dehydrogenase mRNA. Values
represent the mean7s.e. of six independent experiments. *Po0.05
vs control. (b) Northern blot analysis using a radiolabeled
oligonucleotide probe of Nox1. The chart illustrates the density ratio
of Nox1 to glyceraldehyde-3-phosphate dehydrogenase mRNA.
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Figure 4 | Effect of IFN-c on p22phox protein expression. (a)
Western blot analysis using the p22phox antibody shows that IFN-g
increased p22phox protein expression within 6 h. Values represent
the mean7s.e. of four independent experiments. *Po0.01 vs control.
(b) Western blot analysis using the p22phox antibody shows that the
JAK2 inhibitor AG490 inhibited IFN-g-induced p22phox expression at
24 h. Values represent the mean7s.e. of four independent
experiments. *Po0.01 vs control. (c) Western blot analysis using the
p22phox antibody shows that flavin-containing enzyme inhibitor DPI
inhibited IFN-g-induced p22phox expression at 24 h. Values represent
the mean7s.e. of four independent experiments. *Po0.01 vs
unstimulated control, **Po0.01 vs unstimulated control with DPI.
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model, IFN-g is required for crescent formation develop-
ment.18,19 Previous reports have indicated that IFN-g plays an
important role in glomerular nephritis; however, the
molecular mechanisms of IFN-g in glomerular cells are
unclear.
Superoxide anions are recognized as being mediators of
intracellular signaling cascades and are known to participate
in kidney diseases such as glomerulonephritis.10,20 A major
source of O2
 in the kidney is NAD(P)H oxidase in mesangial
cells.12 The NAD(P)H oxidase of phagocytic cells is
composed of the 22 kDa alpha-subunit (p22phox) and
91 kDa beta-subunit (gp91phox) membrane components,
the cytosolic components p47phox and p67phox, and the
small molecular weight G-protein Rac. However, NAD(P)H
oxidases in mesangial cells consist of p22phox, p47phox,
p67phox, Rac, and a homologue of gp91phox, Nox1, or
Nox4.12,21 Much evidence has accumulated, which indicates
that ROS production is associated with the progression of
renal injury.11 We have previously shown that a superoxide
dismutase mimetic, tempol, attenuates renal damage induced
in severe hypertension.22 Moreover, antioxidants prevent
renal injuries induced in nephritis.10 Oxidative stress in
nephritis has an important role; however, the molecular
mechanism of how it is induced in glomerular cells remains
undetermined. In this study, IFN-g increased p22phox and
NAD(P)H oxidase activity via the JAK–STAT pathway (as
shown in Figure 6), results that elucidated the intracellular
signaling of ROS production by IFN-g.
Glomerular mesangial cells have similar characteristics to
those of monocytes and vascular smooth muscle cells.23,24 In
monocytes, IFN-g induces gp91phox gene transcription via
activation of STAT-1a, which translocates to the nucleus as a
transcriptionally active homodimer and binds to the GAS
element.25 Additionally, Nox1 gene expression is induced in
vascular smooth muscle cells during some pathological
conditions.26 We expected that IFN-g would stimulate
Nox1 gene transcription via the JAK/STAT pathway, as has
been previously reported for other cells, because the
mesangial cells we used in this study have similar character-
istics to monocytes and vascular smooth muscle cells. We did
detect mRNA for Nox1, a homologue to gp91phox in HMCs;
however, IFN-g did not increase the expression of Nox1
mRNA (Figure 3b). We also investigated whether other
components of NAD(P)H oxidase, such as Nox4 and
p22phox, are regulated by IFN-g. Although Nox4 is known
as a gp91phox homologue in whole kidney,21 we were not
able to detect mRNA for either Nox4 or gp91phox in HMCs
by Northern blot analysis (data not shown). We also
examined p47phox and p67phox mRNA using real-time
reverse transcriptase-polymerase chain reaction analysis,
protein expression, and translocation by Western blot
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Figure 5 | Effect of IFN-c on HMCs O2
 production. (a) HMCs were
treated with IFN-g (1000 U/ml) for indicated times. Production of O2

was measured by lucigenin-ECL. Values are normalized to the cell
counts and represent the mean7s.e. of 12 independent experiments.
*Po0.01 vs control. (b) IFN-g (1000 U/ml) alone or IFN-g with 10mmol/
l DPI or AG490 were applied to HMCs for 24 h. Both DPI and AG490
completely inhibited IFN-g-induced O2
 production. Values are
normalized to cell counts and represent the mean7s.e. of 12
independent experiments. *Po0.01 vs unstimulated control.
(c) Western blot analysis using the p22phox antibody and b-actin
antibody (upper and lower pictures, respectively). HMCs were
transfected with scrambled (black column) or p22phox-specific siRNA
(gray column). In HMCs transfected with scrambled siRNA, IFN-g
increased O2
 production. Transfection with p22phox-specific siRNA
inhibited IFN-g-induced O2
 production. *Po0.01 vs unstimulated
control.
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Figure 6 | Proposed mechanism of IFN-c-induced O2
 production
via the JAK–STAT pathway. IFN-g stimulated the JAK/STAT pathway
to activate the transcriptional potency of the downstream GAS site
in cell nuclei. The expression of p22phox mRNA and protein, one of
the membrane components of NAD(P)H oxidase, was increased
by IFN-g in HMCs.
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analysis, we could not detect any significant changes (data
not shown). Finally, we determined that IFN-g upregulated
p22phox in HMCs. We previously reported that p22phox is
essential for NAD(P)H oxidase activity in some cell lines.27 A
recent report has shown that p22phox is highly expressed at
the same location as Nox1 or Nox4 in the kidney, and
endogenous p22phox expression is required for the activity of
Nox1 or Nox4.28 Yagisawa et al.29 reported that the amounts
of p22phox, p67phox, and p47phox, but not gp91phox, are
correlated with the level of NAD(P)H oxidase activity in
phagocytes. Inhibition of IFN-g-induced ROS production by
transfection with p22phox-specific siRNA (Figure 5c) suggest
that induction of p22phox, a membrane-bound component
of NAD(P)H oxidase, by IFN-g might therefore be associated
with NAD(P)H oxidase activity in HMCs.
In conclusion, this study is believed to be the first to show
that human IFN-g increases the production of O2
 in HMCs
via NAD(P)H oxidase. IFN-g stimulated JAK/STAT pathways
to activate the transcriptional potency of the downstream
GAS site in cell nuclei. The expression of p22phox, one of the
membrane components of NAD(P)H oxidase, was increased
by IFN-g in HMCs. We have, in this study, provided evidence
of a possible mechanism for the production of O2
 in cases of
glomerulonephritis with inflammatory conditions.
MATERIALS AND METHODS
Cell culture
HMCs were purchased from Cambrex (East Rutherford, NJ, USA).
HMCs were grown in MsGM Bullet Kit (Cambrex) containing 5%
fetal bovine serum until confluent conditions were achieved. The
medium was subsequently switched to a serum-free MsGM for 24 h.
In each experiment, HMCs were stimulated with 1000 U/ml
recombinant human IFN-g (Sigma, St Louis, MO, USA). In
preliminary experiments, to determine the dose–response relation-
ship, 1000 U/ml IFN-g was determined to induce the maximum level
of STAT-1a phosphorylation in these cells (data not shown).
Transfection with siRNA
Transfection of HMCs with siRNA was performed according to the
manufacturer’s protocol (Invitrogen, Carlsbad, CA, USA). Briefly, the
day before transfection, HMCs were grown for 24 h in six-well plates
and allowed to reach 50% confluence in growth medium without
antibiotics. Specific siRNA of p22phox (Stealth Select RNAi,
Invitrogen) or scrambled siRNA (Stealth RNAi Nagative control Hi
GC, Invitrogen) was used at a final concentration of 50 nM, and
Lipofectamine 2000 (Invitrogen) was used at 1/250 (v/v). After 24 h
transfection, cells were washed and stimulated with or without IFN-g.
Western blot analysis
Proteins were extracted from the HMCs and protein concentration
was determined using the Lowry method. Total protein extracts
(30mg) were electrophoretically separated using 10% sodium
dodecyl sulfate-polyacrylamide gels at 200 V for 1 h. Proteins were
subsequently transferred electrophoretically onto a Hybond-ECL
polyvinylidene difluoride membrane (Amersham, Piscataway, NJ,
USA). Blots were blocked overnight at 41C with 5% skimmed milk
in phosphate-buffered saline within 0.1% Tween 20 (137 mmol/l
NaCl, 8.1 mmol/l Na2HPO4  12H2O, 2.68 mmol/l KCl, 1.47 mmol/l
KH2PO4, 0.05% Tween 20). Blots were incubated for 1 h with
human polyclonal antibodies (1:1000 dilution) for either phos-
phorylated STAT-1a (Tyr-701), STAT-1a (Santa Cruz, Santa Cruz,
CA, USA), or p22phox. After washing, blots were incubated with
horseradish peroxidase-conjugated anti-goat immunoglobulin G
(1:6000 dilution) in phosphate-buffered saline within 0.1% Tween
20 containing 5% skimmed milk. The reaction bands from
chemiluminescence signals were detected using an ECL detection
kit (Amersham). To confirm reproducibility, we performed at least
four independent representative experiments.
Preparation of nuclear extracts
Nuclear extracts were prepared from HMCs as previously described
by Kumatori et al.,25 with slight modifications. Briefly, following cell
stimulation for indicated times, HMCs were swollen in ice-cold
buffer A (10 mM N-2-hydroxyethylpiperazine-N0-2-ethanesulfonic
acid (pH 7.9), 10 mM KCl, 0.1 mM ethyleneglycol tetraacetate, 0.1 mM
ethylenediaminetetraacetic acid, 1 mM dithiothreitol, Complete
Protease Inhibitor Mixture (Roche Diagnostics, Basel, Switzer-
land)/Phophatase Inhibitor Mixture I and II (Sigma)). After 15 min
incubation at 41C, the cells were lysed in 0.6% Nonidet P-40 (Sigma)
by vigorous vortexing for 10 s. After centrifugation at 5000 r.p.m.
(1700 g) for 1 min, the supernatant was discarded, and the pellets
resuspended in ice-cold buffer C (20 mM N-2-hydroxyethylpiper-
azine-N0-2-ethanesulfonic acid (pH 7.9), 0.4 M KCl, 1 mM ethyle-
neglycol tetraacetate, 1 mM ethylenediaminetetraacetic acid, 1 mM
dithiothreitol, Complete Protease Inhibitor Mixture/Phophatase
Inhibitor Mixture I and II) and then incubated at 41C for 20 min.
Nuclear extracts were separated by centrifugation at 15 000 r.p.m.
(18 000 g) for 5 min at 41C and then stored in aliquots at 801C
until assay.
Electrophoretic mobility shift assay
EMSA was performed as previously described by Choudhury et al.30
We used a double-stranded oligonucleotide corresponding to the
GAS (ATATTCCTGTAAGTG) for EMSA. The annealed oligonucleo-
tide was labeled with [g-32P]ATP (Amersham) using T4 polynucleo-
tide kinase (Promega, Madison, MI, USA). Eight micrograms of the
nuclear protein aliquot (1 mg/ml) was incubated in 4 ml binding
buffer (35 mM N-2-hydroxyethylpiperazine-N[prime]-2-ethanesul-
fonic acid KOH (pH 7.8), 0.5 mM ethylenediaminetetraacetic acid,
0.5 mM dithiothreitol 10% glycerol) with 10 mg/ml poly-dIdC and
50 000 counts per min radiolabeled oligonucleotide for 30 min at
room temperature. For competition experiments, a 50-fold excess of
non-labeled oligonucleotide was used. Some extracts were incubated
on ice with an antibody to STAT-1a (8 mg/ml final concentration)
for 30 min before the binding reaction. Finally, the samples were
separated on a native 5% polyacrylamide gel. After electrophoresis,
the gel was dried and subjected to autoradiography. To confirm the
reproducibility of this phenomenon, we examined at least four
independent representative experiments.
Northern blot analysis
Total RNA was extracted using ISOGEN (Nippon Gene, Tokyo,
Japan) in accordance with the manufacturer’s instructions, and was
quantified using a spectrophotometer. Total RNA (20 mg) was
subjected to electrophoresis in a 12.3 M formaldehyde/1% agarose gel
and then transferred to a MAGNA nylon transfer membrane
(Osmonics, Westborough, MA, USA). Probe labeling was performed
using the random primer labeling method with [32P]dCTP and the
Prime-It II kit (Stratagene, La Jolla, CA, USA). Unincorporated 32P
was removed using Biospin P30 columns (Bio-Rad, Hercules, CA,
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USA). The cDNA used to prepare the Nox1 probe was obtained by
polymerase chain reaction amplification with sequence-specific
primers (Nox1: 50-CCCAGCAGAAGGTTGTGATT-30 and 50-CGG
TGAGGAAGAGACGGTAG-30), based on the published sequence,31
and subcloned. The p22phox probe was full-length cDNA as
described previously.32 Membranes were also hybridized with the
glyceraldehyde-3-phosphate dehydrogenase gene as an internal
control for RNA loading and transfer efficiency. Membranes were
read by a BAS 1000 (Fujifilm, Kanagawa, Japan) and the intensity of
the band analyzed by densitometry.
Measurement of O2

The production of O2
 was measured by lucigenin-enhanced
chemiluminescence as described previously.33 Briefly, cells treated
with or without IFN-g were detached by trypsin/ethylenediaminete-
traacetic acid. After washing with phosphate-buffered saline,
10 mmol/l lucigenin was added to the cell suspension and
chemiluminescence measured by a BLR-301 luminometer (Aloka,
Tokyo, Japan). The generation of O2
 was determined from
differences in counts in either the absence or presence of the O2

scavenger, 4,5-dihydroxy-1, 3-benzenedisulfonic acid (Tiron; Sig-
ma). Values were normalized to cell numbers. To confirm the
specificity of NAD(P)H oxidase activity, other cells were pretreated
with IFN-g in the presence of 10 mmol/l DPI (Sigma), a flavin-
containing enzyme inhibitor.
Statistics
All data are shown as means7s.e. Differences were evaluated using
one-way analysis of variance followed by a t-test. Statistical
significance was defined as Po0.05.
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